Functional Areas
- Functional Areas
- Legal Framework
- Project Document
- The Grant Agreement
- UNDP-Global Fund Grant Regulations
- Grant Confirmation
- Grant Confirmation: Face Sheet
- Grant Confirmation: Conditions
- Grant Confirmation: Conditions Precedent (CP)
- Grant Confirmation: Special Conditions (SCs)
- Grant Confirmation: Limited Liability Clause
- Grant Confirmation: Schedule 1, Integrated Grant Description
- Grant Confirmation: Schedule 1, Performance Framework
- Grant Confirmation: Schedule 1, Summary Budget
- Implementation Letters and Performance Letters
- Agreements with Sub-recipients
- Agreements with Sub-sub-recipients
- Signing Legal Agreements and Requests for Disbursement
- Language of the Grant Agreement and other Legal Instruments
- Amending Legal Agreements
- Other Legal and Implementation Considerations
- Legal Framework for Other UNDP Support Roles
- Health Product Management
- Sub-recipient Management
- Capacity Development
- Interim Principal Recipient of Global Fund Grants
- A Strategic Approach to Capacity Development
- Resilience and Sustainability
- Legal and Policy Enabling Environment
- Functional Capacities
- Capacity Development and Transition
- Transition
- Capacity Development Objectives and Transition Milestones
- Capacity Development Results – Evidence From Country Experiences
- Capacity development and Transition Planning Process
- Capacity Development and Transition – Lessons Learned
- Risk Management
- Audit and Investigations
- Human Rights, key Populations and Gender
- Human Resources
- Legal Framework
In-vitro Diagnostic (IVD) Products
In-vitro Diagnostic (IVD) Products
All diagnostic products procured through UNDP health procurement support must be 1) in conformity with WHO guidance (e.g., WHO Essential Diagnostic List – EDL), 2) consistent with relevant national laboratory policies and strategic plans, 3) take into account harmonized and standardized practices (e.g., national testing algorithms), 4) consider the physical infrastructure and biosafety level of the laboratory, 5) must take into account the structure, functioning and capacity of the laboratory system (human resources, network, communication system, and specimen transport systems at and between each level of service), and 6) be effectively coordinated with laboratory services and other funding sources.
For entities submitting requests to UNDP for the procurement of diagnostic products that are not included WHO guidance, the requests should be supported by an appropriate justification with supporting evidence (e.g., National Testing Algorithm). These will be assessed by the UNDP QA Expert Committee to determine compliance with UNDP’s general principles for the procurement of health products. Such requests should be submitted to the GFPHST Senior Health PSM Advisor through the GFPHST HPM Specialist focal point.
All diagnostic products must be procured using their generic name or description. Where 1) a National validated testing algorithm, or 2) Closed equipment testing systems that require reagents and consumables that are specific to a diagnostic platform, or 3) National standardized and harmonized practices exists, it may be permissible to procure using a brand (proprietary) name and/or specific product catalogue number. Using no or restricted competition requires prior approval from GFPHST HPM Specialists and, when grant funds are being used, from the Global Fund.
While WHO has recommended diagnostic and testing algorithms for HIV/AIDS, tuberculosis (TB), malaria and hepatitis, and these can be helpful to governments as reference for the development of national guidelines, it is important that national algorithms are established and are tailored to local requirements, ensuring national ownership of the guidelines.
In-vitro Diagnostic (IVD) Products
Diagnostics for Research Use Only (RUO)
READ MORE
Resources
Functional Area: Health Product Management Project Stage: Grant Implementation Author: WHO Language: English Type: Database or Catalogue Topic: Procurement of pharmaceutical products, Essential Medicine Resource File Format: Link Resource Accessibility: Publicly accessible
Functional Area: Health Product Management Project Stage: Grant Implementation Author: The Global Fund Language: English Type: Policies, Procedures and guidance Topic: QA Policies, Quality Control Measures, UNDP Quality Assurance Policy, Quality Assurance Resource File Format: Link Resource Accessibility: Publicly accessible
Functional Area: Health Product Management Project Stage: Grant Implementation Author: WHO Language: English Type: Policies, Procedures and guidance Topic: Resource File Format: PDF Resource Accessibility: Publicly accessible
Functional Area: Health Product Management Project Stage: Grant Implementation Author: WHO Language: English Type: Policies, Procedures and guidance Topic: Resource File Format: Link Resource Accessibility: Publicly accessible